Shiloh
Editor, Senior Moderator
Re: Indonesia requests to USA, WHO and Big Pharma
Re: Indonesia requests to USA, WHO and Big Pharma
Source: http://www.antara.co.id/en/arc/2008...2-in-indonesia-awaiting-house-recommendation/
06/19/08 22:17
Further presence of Namru-2 in Indonesia awaiting house recommendation
By Eliswan Azly
Jakarta (ANTARA News) - The controversial presence of the US Naval Medical Research Unit 2?s (Namru2) in Indonesia which is now under negotiations between Indonesia and the United States is awaiting a recommendation of the Indonesian House of Representatives (DPR).
The government`s decision on whether or not the US Naval Medical Research Unit-2 may stay somewhat longer in the country would depend on a recommendation of the House of Representatives (DPR), Health Minister Siti Fadilah Supari said
"The question is now still undecided. The US has sent us its revised proposal and we have yet to consider it. But the key to this matter is in the hands of the DPR. The DPR represents the people. If the people wants NAMRU-2 to stay somewhat longer, so be it," Health Minister Siti Fadilah said during a hearing with Ad Hoc Committee IV of the Regional Representatives Council (DPD) in Jakarta on Thursday.
But even if the government and parliament eventually agreed to continue the cooperation with NAMRU-2, it should be carried out on the basis of the relevant Indonesian laws on international cooperation, she said.
"And it is my understanding that Indonesia always cooperates with other countries with due observance of its active and independent foreign policy, its own laws and in ways benefiting the people," Siti said.
The government not long ago expressed its intention to renew its agreement with Washington on NAMRU-2`s presence and operations in Indonesia.
The draft of the new agreement was sent to the US government which had sent it back to Indonesia last May. The Indonesian government is to discuss the returned draft internally before making a decision regarding the matter.
Various quarters in the country recently questioned the continued presence and operations of NAMRU-2 in Indonesia, including the US demand for diplomatic immunity for US citizens working at the NAMRU-2 laboratory for research on tropical diseases.
The opposition came from legislators and professionals in the country.
Mutammimul Ula, a member of the House of Representatives` Commission I which deals with foreign affairs, urged the government to stop and take over the operation of the Namru-2 laboratory. In the 30 years of operation in Indonesia, Namru-2 failed to provide the country with concrete results for the defense and health sectors.
Other legislators, according to him, agreed to the drafting of a Memorandum of Understanding (MoU) released by the Foreign Ministry to be cancelled.
Indonesia has established cooperation with various institutions like the World Health Organization (WHO) on research and data transfer. It is for that reason that an extension of cooperation with Namru-2 is no longer necessary.
Furthermore, he said the government should conduct an investigation on an allegation that Namru-2 staffers had been involved in intelligence operations. "In addition, the US embassy in Jakarta should provide evidence that Namru-2 is not an institution engaged in espionage."
This legislator however believed that the cooperation needs to be based on transparency and equality and respect for sovereignty and mutual benefit.
Not only the legislator, Joserizal Junalis of the Medical Emergency Rescue Committee (MER-C) and Munarman of An Nashr Institute also called on the government of Indonesia not to extend its cooperation with the US Naval Medical Research Institute.
In their statements, the presence of Namru-2 in Indonesia for over 30 years now was reported to have failed to benefit the people. An agreement between the Indonesian and US governments on Namru-2 operations reached on January 16, 1970, was believed to have caused a loss to Indonesia because of the diplomatic immunity of the Namru-2 staff members, their tax exemption and free accommodation.
Namru-2 was also believed to have violated the cooperation, because they had been continuing their research work although their contract had expired.
More saddening, Namru-2 was also reported to be lacking in transparency their information for the Indonesian government and that their operations were allegedly linked to US intelligence operations in Indonesia.
In the meantime, the US embassy in Jakarta said that Namru-2 was a transparent organization which only conducted medical and scientific research work focusing on tropical diseases.
The biomedical research laboratory of Namru-2, according to the US embassy, conducted a series of research work on infectious diseases to serve the interest of the US and Indonesian health ministry as well as the health of the international community.
Commenting on the diplomatic immunity of all NAMRU-2 staff members which has become a controversial issue, Indonesian Defense Minister Juwono Sudarsono said that the Indonesian government persisted in granting diplomatic immunity to only two US Namru-2 staff members.
"We are sticking to our stance that not all of Namru-2 officers deserved diplomatic immunity, but only two of the 20 US naval officers with Namru-2," he said.
Besides restricting the number of Namru-2 staff enjoying diplomatic immunity, Indonesia also insisted that doctors of the Indonesian Navy be assigned in Namru-2 as supervisors, he said.
The need to assign Indonesian supervisors was prompted by the fact that so far the activities carried out by Namru-2 officers lacked transparency.
"We want Indonesian naval officers to be involved in the activities of NAMRU-2," the minister said.
Indonesia and the United States are still negotiating several points on the resumption of their cooperation on Namru-2.
The search work of NAMRU-2 was more focused on malaria, virus-related diseases and other infectious diseases including bird flu. (*)
COPYRIGHT ? 2008
Re: Indonesia requests to USA, WHO and Big Pharma
Source: http://www.antara.co.id/en/arc/2008...2-in-indonesia-awaiting-house-recommendation/
06/19/08 22:17
Further presence of Namru-2 in Indonesia awaiting house recommendation
By Eliswan Azly
Jakarta (ANTARA News) - The controversial presence of the US Naval Medical Research Unit 2?s (Namru2) in Indonesia which is now under negotiations between Indonesia and the United States is awaiting a recommendation of the Indonesian House of Representatives (DPR).
The government`s decision on whether or not the US Naval Medical Research Unit-2 may stay somewhat longer in the country would depend on a recommendation of the House of Representatives (DPR), Health Minister Siti Fadilah Supari said
"The question is now still undecided. The US has sent us its revised proposal and we have yet to consider it. But the key to this matter is in the hands of the DPR. The DPR represents the people. If the people wants NAMRU-2 to stay somewhat longer, so be it," Health Minister Siti Fadilah said during a hearing with Ad Hoc Committee IV of the Regional Representatives Council (DPD) in Jakarta on Thursday.
But even if the government and parliament eventually agreed to continue the cooperation with NAMRU-2, it should be carried out on the basis of the relevant Indonesian laws on international cooperation, she said.
"And it is my understanding that Indonesia always cooperates with other countries with due observance of its active and independent foreign policy, its own laws and in ways benefiting the people," Siti said.
The government not long ago expressed its intention to renew its agreement with Washington on NAMRU-2`s presence and operations in Indonesia.
The draft of the new agreement was sent to the US government which had sent it back to Indonesia last May. The Indonesian government is to discuss the returned draft internally before making a decision regarding the matter.
Various quarters in the country recently questioned the continued presence and operations of NAMRU-2 in Indonesia, including the US demand for diplomatic immunity for US citizens working at the NAMRU-2 laboratory for research on tropical diseases.
The opposition came from legislators and professionals in the country.
Mutammimul Ula, a member of the House of Representatives` Commission I which deals with foreign affairs, urged the government to stop and take over the operation of the Namru-2 laboratory. In the 30 years of operation in Indonesia, Namru-2 failed to provide the country with concrete results for the defense and health sectors.
Other legislators, according to him, agreed to the drafting of a Memorandum of Understanding (MoU) released by the Foreign Ministry to be cancelled.
Indonesia has established cooperation with various institutions like the World Health Organization (WHO) on research and data transfer. It is for that reason that an extension of cooperation with Namru-2 is no longer necessary.
Furthermore, he said the government should conduct an investigation on an allegation that Namru-2 staffers had been involved in intelligence operations. "In addition, the US embassy in Jakarta should provide evidence that Namru-2 is not an institution engaged in espionage."
This legislator however believed that the cooperation needs to be based on transparency and equality and respect for sovereignty and mutual benefit.
Not only the legislator, Joserizal Junalis of the Medical Emergency Rescue Committee (MER-C) and Munarman of An Nashr Institute also called on the government of Indonesia not to extend its cooperation with the US Naval Medical Research Institute.
In their statements, the presence of Namru-2 in Indonesia for over 30 years now was reported to have failed to benefit the people. An agreement between the Indonesian and US governments on Namru-2 operations reached on January 16, 1970, was believed to have caused a loss to Indonesia because of the diplomatic immunity of the Namru-2 staff members, their tax exemption and free accommodation.
Namru-2 was also believed to have violated the cooperation, because they had been continuing their research work although their contract had expired.
More saddening, Namru-2 was also reported to be lacking in transparency their information for the Indonesian government and that their operations were allegedly linked to US intelligence operations in Indonesia.
In the meantime, the US embassy in Jakarta said that Namru-2 was a transparent organization which only conducted medical and scientific research work focusing on tropical diseases.
The biomedical research laboratory of Namru-2, according to the US embassy, conducted a series of research work on infectious diseases to serve the interest of the US and Indonesian health ministry as well as the health of the international community.
Commenting on the diplomatic immunity of all NAMRU-2 staff members which has become a controversial issue, Indonesian Defense Minister Juwono Sudarsono said that the Indonesian government persisted in granting diplomatic immunity to only two US Namru-2 staff members.
"We are sticking to our stance that not all of Namru-2 officers deserved diplomatic immunity, but only two of the 20 US naval officers with Namru-2," he said.
Besides restricting the number of Namru-2 staff enjoying diplomatic immunity, Indonesia also insisted that doctors of the Indonesian Navy be assigned in Namru-2 as supervisors, he said.
The need to assign Indonesian supervisors was prompted by the fact that so far the activities carried out by Namru-2 officers lacked transparency.
"We want Indonesian naval officers to be involved in the activities of NAMRU-2," the minister said.
Indonesia and the United States are still negotiating several points on the resumption of their cooperation on Namru-2.
The search work of NAMRU-2 was more focused on malaria, virus-related diseases and other infectious diseases including bird flu. (*)
COPYRIGHT ? 2008